The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...

Capricor Therapeutics saw its shares fall 13% by the end of trading Monday as its investigational cell therapy deramiocel for ...

The process was developed last November in response to a South Carolina Department of Education memo seeking to provide ...

Good morning and welcome to Kelly Services First Quarter 2025 Earnings Conference Call. All parties will be on listen-only until the question-and-answer portion of the presentation. Today's call is ...

Spencer resident enjoys football and basketball but holds a special place for baseball, in which he stars at plate and on ...

Children's Wisconsin says it accidentally ‘discarded’ the frozen portion of a young woman's donated brain. Ashtyn Fellenz, ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company”) today announced financial results for the first quarter ended March 31, 2025.

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation there ...

Most veterans and their family members are concerned about proposed cuts at the U.S. Department of Veterans Affairs, ...

The U.S. government is pushing to redomesticate the manufacturing of pharmaceutical, biotech, gene therapy, and medical device products, both ...